Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment

Minimal residual disease (MRD) quantified after induction treatment of childhood acute lymphoblastic leukemia (ALL) predicts risk of relapse. It has been assumed that early relapses derive from a residual population of leukemic cells, which is still present after induction and that relapsed disease...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Eckert, Cornelia (VerfasserIn) , Flohr, T. (VerfasserIn) , Köhler, Rolf (VerfasserIn) , Hagedorn, N. (VerfasserIn) , Moericke, A. (VerfasserIn) , Stanulla, M. (VerfasserIn) , Kirschner-Schwabe, R. (VerfasserIn) , Cario, G. (VerfasserIn) , Stackelberg, Av (VerfasserIn) , Bartram, Claus R. (VerfasserIn) , Henze, G. (VerfasserIn) , Schrappe, M. (VerfasserIn) , Schrauder, A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 06 May 2011
In: Leukemia
Year: 2011, Jahrgang: 25, Heft: 8, Pages: 1305-1313
ISSN:1476-5551
DOI:10.1038/leu.2011.89
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/leu.2011.89
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/leu201189
Volltext
Verfasserangaben:C. Eckert, T. Flohr, R. Koehler, N. Hagedorn, A. Moericke, M. Stanulla, R. Kirschner-Schwabe, G. Cario, Av Stackelberg, C.R. Bartram, G. Henze, M. Schrappe and A. Schrauder

MARC

LEADER 00000caa a2200000 c 4500
001 1797453343
003 DE-627
005 20220820160425.0
007 cr uuu---uuuuu
008 220404s2011 xx |||||o 00| ||eng c
024 7 |a 10.1038/leu.2011.89  |2 doi 
035 |a (DE-627)1797453343 
035 |a (DE-599)KXP1797453343 
035 |a (OCoLC)1341458437 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Eckert, Cornelia  |d 1971-  |e VerfasserIn  |0 (DE-588)128920998  |0 (DE-627)385334532  |0 (DE-576)297400290  |4 aut 
245 1 0 |a Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment  |c C. Eckert, T. Flohr, R. Koehler, N. Hagedorn, A. Moericke, M. Stanulla, R. Kirschner-Schwabe, G. Cario, Av Stackelberg, C.R. Bartram, G. Henze, M. Schrappe and A. Schrauder 
264 1 |c 06 May 2011 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.04.2022 
520 |a Minimal residual disease (MRD) quantified after induction treatment of childhood acute lymphoblastic leukemia (ALL) predicts risk of relapse. It has been assumed that early relapses derive from a residual population of leukemic cells, which is still present after induction and that relapsed disease will consequently be more resistant to treatment. To test these hypotheses, we performed a prospective study on patients treated according to the frontline-trial ALL-BFM 2000, which used MRD response for risk-group stratification. Patients (n=45) showed a median time to relapse of 1.5 years. In 89% of patients at least one T-cell-receptor/immunoglobulin gene rearrangement chosen for initial MRD quantification remained stable; however, at least one of the preferred markers for MRD stratification at relapse was different to diagnosis in 50% of patients. A similar proportion of very early, early and late relapses appeared to gain a marker at relapse although backtracking-analysis revealed that in 77% of cases, the gained markers were present as small sub-clones at initial diagnosis. Comparing initial and relapse MRD response to induction, 38% of patients showed a similar, 38% a better and 25% a poorer response after relapse. These data demonstrate an unexpectedly high clonal heterogeneity among very early/early relapses and challenge some current assumptions about relapsed ALL. 
650 4 |a Acute lymphocytic leukaemia 
650 4 |a Cancer therapy 
700 1 |a Flohr, T.  |e VerfasserIn  |4 aut 
700 1 |a Köhler, Rolf  |d 1966-  |e VerfasserIn  |0 (DE-588)12289751X  |0 (DE-627)082221545  |0 (DE-576)293468427  |4 aut 
700 1 |a Hagedorn, N.  |e VerfasserIn  |4 aut 
700 1 |a Moericke, A.  |e VerfasserIn  |4 aut 
700 1 |a Stanulla, M.  |e VerfasserIn  |4 aut 
700 1 |a Kirschner-Schwabe, R.  |e VerfasserIn  |4 aut 
700 1 |a Cario, G.  |e VerfasserIn  |4 aut 
700 1 |a Stackelberg, Av  |e VerfasserIn  |4 aut 
700 1 |a Bartram, Claus R.  |d 1952-  |e VerfasserIn  |0 (DE-588)139758518  |0 (DE-627)613089502  |0 (DE-576)312997159  |4 aut 
700 1 |a Henze, G.  |e VerfasserIn  |4 aut 
700 1 |a Schrappe, M.  |e VerfasserIn  |4 aut 
700 1 |a Schrauder, A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Leukemia  |d London : Springer Nature, 1997  |g 25(2011), 8, Seite 1305-1313  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment 
773 1 8 |g volume:25  |g year:2011  |g number:8  |g pages:1305-1313  |g extent:9  |a Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment 
856 4 0 |u https://doi.org/10.1038/leu.2011.89  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.nature.com/articles/leu201189  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220404 
993 |a Article 
994 |a 2011 
998 |g 139758518  |a Bartram, Claus R.  |m 139758518:Bartram, Claus R.  |d 910000  |d 911500  |e 910000PB139758518  |e 911500PB139758518  |k 0/910000/  |k 1/910000/911500/  |p 10 
998 |g 12289751X  |a Köhler, Rolf  |m 12289751X:Köhler, Rolf  |d 910000  |d 911500  |e 910000PK12289751X  |e 911500PK12289751X  |k 0/910000/  |k 1/910000/911500/  |p 3 
999 |a KXP-PPN1797453343  |e 4111871844 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"doi":["10.1038/leu.2011.89"],"eki":["1797453343"]},"origin":[{"dateIssuedDisp":"06 May 2011","dateIssuedKey":"2011"}],"name":{"displayForm":["C. Eckert, T. Flohr, R. Koehler, N. Hagedorn, A. Moericke, M. Stanulla, R. Kirschner-Schwabe, G. Cario, Av Stackelberg, C.R. Bartram, G. Henze, M. Schrappe and A. Schrauder"]},"recId":"1797453343","person":[{"family":"Eckert","given":"Cornelia","role":"aut","display":"Eckert, Cornelia"},{"display":"Flohr, T.","role":"aut","given":"T.","family":"Flohr"},{"display":"Köhler, Rolf","given":"Rolf","role":"aut","family":"Köhler"},{"given":"N.","role":"aut","family":"Hagedorn","display":"Hagedorn, N."},{"display":"Moericke, A.","given":"A.","role":"aut","family":"Moericke"},{"display":"Stanulla, M.","family":"Stanulla","given":"M.","role":"aut"},{"given":"R.","role":"aut","family":"Kirschner-Schwabe","display":"Kirschner-Schwabe, R."},{"display":"Cario, G.","role":"aut","given":"G.","family":"Cario"},{"family":"Stackelberg","role":"aut","given":"Av","display":"Stackelberg, Av"},{"given":"Claus R.","role":"aut","family":"Bartram","display":"Bartram, Claus R."},{"display":"Henze, G.","family":"Henze","given":"G.","role":"aut"},{"display":"Schrappe, M.","given":"M.","role":"aut","family":"Schrappe"},{"display":"Schrauder, A.","role":"aut","given":"A.","family":"Schrauder"}],"title":[{"title":"Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment","title_sort":"Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatment"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"9 S."}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 15.03.04"],"language":["eng"],"pubHistory":["Nachgewiesen 11.1997 -"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"recId":"32046699X","disp":"Very early/early relapses of acute lymphoblastic leukemia show unexpected changes of clonal markers and high heterogeneity in response to initial and relapse treatmentLeukemia","id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"origin":[{"dateIssuedDisp":"1997-","dateIssuedKey":"1997","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke"}],"part":{"year":"2011","issue":"8","text":"25(2011), 8, Seite 1305-1313","extent":"9","pages":"1305-1313","volume":"25"}}],"note":["Gesehen am 04.04.2022"]} 
SRT |a ECKERTCORNVERYEARLYE0620